MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-18-2024
Novo Integrated Sciences Cost of Revenue 2011-2026 | NVOS
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Novo Integrated Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.55 M | 7.62 M | 6.94 M | 5.48 M | 4.8 M | 5.9 M | 5.47 M | 4.99 M | 4.67 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.62 M | 4.67 M | 5.94 M |
Quarterly Cost of Revenue Novo Integrated Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.25 M | 1.85 M | 1.95 M | - | 1.98 M | 1.59 M | 1.68 M | - | 11.4 M | 1.65 M | 1.9 M | 3.77 M | 1.1 M | 1.32 M | 1.34 M | 3.78 M | 560 K | 1.34 M | 1.63 M | 4.31 M | 1.56 M | 1.63 M | 1.43 M | 4.13 M | 1.42 M | 1.43 M | 1.41 M | 3.73 M | 1.38 M | 1.41 M | 1.16 M | - | 1.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.4 M | 560 K | 2.24 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B |  USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
Chemed Corporation
CHE
|
1.58 B | $ 373.89 | 0.13 % | $ 5.62 B | USA |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 22.69 | -2.07 % | $ 2.08 B | USA |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.38 | -1.3 % | $ 121 M | USA |
 |
Community Health Systems
CYH
|
1.86 B | $ 2.92 | -2.01 % | $ 390 M | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.43 M | - | 26.45 % | $ 70.6 M | USA |
 |
Encompass Health Corporation
EHC
|
3.12 B | $ 97.49 | -0.03 % | $ 9.8 B | USA |
|
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M |  China |
 |
Phibro Animal Health Corporation
PAHC
|
896 M | $ 55.48 | 3.12 % | $ 2.25 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 18.49 | 0.54 % | $ 724 M | USA |
 |
American Shared Hospital Services
AMS
|
19.2 M | $ 1.9 | -4.04 % | $ 12.3 M | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.65 | -1.35 % | $ 478 M | China |
 |
National HealthCare Corporation
NHC
|
921 M | $ 161.99 | 0.15 % | $ 2.51 B | USA |
 |
Option Care Health
OPCH
|
4.56 B | $ 28.41 | - | $ 4.61 B | USA |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
Select Medical Holdings Corporation
SEM
|
4.82 B | $ 16.27 | - | $ 2 B | USA |
 |
Surgery Partners
SGRY
|
971 M | $ 12.0 | 0.17 % | $ 1.53 B | USA |
|
Sanara MedTech
SMTI
|
7.85 M | $ 18.08 | -1.42 % | $ 150 M | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
2.12 B | $ 24.9 | 1.84 % | $ 12.4 B | USA |
 |
Addus HomeCare Corporation
ADUS
|
961 M | $ 99.31 | -0.47 % | $ 1.79 B | USA |
 |
Tenet Healthcare Corporation
THC
|
8.7 B | $ 199.63 | -1.86 % | $ 18 B | USA |
 |
U.S. Physical Therapy
USPH
|
462 M | $ 74.7 | -0.66 % | $ 1.13 B | USA |
 |
Healthcare Services Group
HCSG
|
1.6 B | $ 19.38 | -0.77 % | $ 1.4 B | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
Universal Health Services
UHS
|
8.08 B | $ 185.92 | -1.15 % | $ 11.8 B | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
The Ensign Group
ENSG
|
4.02 B | $ 202.92 | 0.24 % | $ 11.6 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 22.03 | 0.59 % | $ 7.05 B |  Germany |
 |
HCA Healthcare
HCA
|
32.9 B | $ 485.72 | -1.79 % | $ 115 B | USA |
 |
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | USA |
 |
MEDNAX
MD
|
1.54 B | $ 20.75 | 0.73 % | $ 1.74 B | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |
 |
The Pennant Group
PNTG
|
769 M | $ 31.02 | -1.12 % | $ 1.07 B | USA |